Form D — Natsar Pharmaceuticals, Inc.
0002134002-26-000001 · filed May 8, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- —
- Total sold
- $4,221,000
- Minimum investment
- $1
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Natsar Pharmaceuticals, Inc.
- CIK
- 2134002
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 4624 TALL MAPLE CT.
ELLICOTT CITY, MD 21043 - Phone
- 410-948-2578
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Venu Raman · Executive OfficerEllicott City, MD Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗